Interferon-γ promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) β2-Reference-Cited by-同舟云学术

Interferon-γ promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) β2

Published:2013-04-18 Issue:8 Volume:228 Page:1774-1783
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Chrobak Izabela,Lenna Stefania,Stawski Lukasz,Trojanowska Maria

Funder

NIH NIAMS

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcp.24337/fullpdf

Reference46 articles.

1. CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis-A longitudinal study;Antonelli;Rheumatology (Oxford),2008

2. IFN-gamma and TNF-alpha induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls;Antonelli;Scand J Rheumatol,2011

3. Endothelial Fli1 deficiency impairs vascular homeostasis: A role in scleroderma vasculopathy;Asano;Am J Pathol,2010

4. Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis;Bellisai;Int J Immunopathol Pharmacol,2011

5. Interferon-gamma: A historical perspective;Billiau;Cytokine Growth Factor Rev,2009

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond VICs: Shedding light on the overlooked VECs in calcific aortic valve disease;Biomedicine & Pharmacotherapy;2024-09

2. Interferon-γ Induces Interleukin-6 Production and Alpha-smooth Muscle Actin Expression in Systemic Sclerosis Fibroblasts;Iranian Journal of Allergy, Asthma and Immunology;2024-04-14

3. Cellular and Molecular Mechanisms of Fibrosis in Systemic Sclerosis;Scleroderma;2024

4. Infections and Systemic Sclerosis;Infection and Autoimmunity;2024

5. An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed;Frontiers in Cardiovascular Medicine;2023-12-21